Advanced glycation end products as risk factors for type 1 diabetes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

There is no cure for type 1 diabetes which manifests in children and adolescents resulting in the need for 5 injections of insulin each day. During this scholarship period, we aim to discover new genetic and blood biomarkers for disease onset in children for use in new born and childhood screening. In addition we will determine if specific environmental factors called advanced glycation end products can contribute to type 1 diabetes via interactions with a specific gene, RAGE.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $80,040.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cell Metabolism

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diabetes mellitus | diabetes prevention | glycation | insulin secretion | islets of Langerhans